4//SEC Filing
TRUEX PAUL F 4
Accession 0001214659-17-005551
CIK 0001316175other
Filed
Sep 6, 8:00 PM ET
Accepted
Sep 7, 6:56 PM ET
Size
4.9 KB
Accession
0001214659-17-005551
Insider Transaction Report
Form 4
TRUEX PAUL F
DirectorPresident and CEO
Transactions
- Purchase
Common Stock
2017-09-07$1.34/sh+5,000$6,700→ 16,793 total(indirect: By Trust)
Footnotes (1)
- [F1]The Reporting Person acquired the shares in the open market and through the 2005 Truex Family Trust u/d/t April 20, 2005. Shares have been adjusted to reflect the issuer's 1-for-8 reverse stock split effectuated on April 28, 2017.
Documents
Issuer
Anthera Pharmaceuticals Inc
CIK 0001316175
Entity typeother
Related Parties
1- filerCIK 0001120362
Filing Metadata
- Form type
- 4
- Filed
- Sep 6, 8:00 PM ET
- Accepted
- Sep 7, 6:56 PM ET
- Size
- 4.9 KB